From FAST channels to connected TV experiences, industry leaders are navigating a rapidly evolving landscape ... Read More ...

Xcel Brands’ Common Stock will continue to trade on the Nasdaq Capital Market (“Nasdaq”) under the symbol “XELB”. The new CUSIP number for the Common Stock following the Reverse Stock Split will be ...

Fulgent Genetics has a low Price/Book ratio and promising drug candidates. Key trial results are expected in May 2025. Read ...

Harmonic will showcase a lineup of cloud and software-based innovations at the NAB Show (April 6-9, Las Vegas Convention Center) At Booth W2821. The company will highlight a range of … The post NAB ...

The fragmentation of media workflows has created significant inefficiencies, with many organizations operating separate ...

Avutometinib plus defactinib granted priority review by FDA in December 2024, under the accelerated approval pathway, for KRAS mutant recurrent LGSOC; PDUFA action date set for June 30, 2025 Filed an ...

A software provider that offers products designed to improve post-production workflows for broadcasters is returning to the NAB Show, and will introduce a post-production collaboration product ...

Q4 2024 earnings insights—revenue growth, revamped sales strategies, and product expansions positioning for a 2025 breakthrough.

At NAB Show (April 6-9, Las Vegas Convention Center) in Booth W2601, LTN will debut live sports, channel distribution and real-time content versioning technologies designed to “drive revenue for ...

The company posted an EPS of $0.39, falling short of the $0.42 forecast. Revenue came in at $33.8 million, below the expected $36.1 million. Despite the miss, the stock showed a modest increase of ...

The company posted an EPS of $0.39, falling short of the $0.42 forecast. Revenue came in at $33.8 million, below the expected $36.1 million. Despite the miss, the stock showed a modest increase of ...